EPICS invents medicines
EPICS is a drug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development
AboutWhat's new at Epics Therapeutics ?
- Press release EPICS Therapeutics Names Franz Obermayr Ph. D., Chief Executive Officer 31.01.22
- Press release Epics Therapeutics Initiates First-in-Human Studies with EP282, an oral Investigational Drug for the treatment of gastrointestinal inflammatory disorders and cancer 12.01.22
- Press release EPICS Therapeutics to Acquire Ogeda former assets, Adding Drug Discovery & Development Capabilities 03.01.19
Barbara Wroblewski
Marketing Communication Manager Europe
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Our mission
EPICS’s mission is to utilize its expertise in drug discovery and development to invent novel clinical agents targeting serious unmet medical needs in oncology